USA Botulinum Toxins Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.

    In the last several years, global market of Botulinum Toxins developed rapidly, with an average growth rate of 14.6%. In 2017, global revenue of Botulinum Toxins is nearly 4000 million USD; the actual production is about 12.4 million units.The classification of Botulinum Toxins includes 50U, 100U and other, and the sales proportion of 50U in 2017 is about 59.3%. Botulinum Toxins is used for medical and cosmetic. Medical was the largest application segment in 2017, the proportion is about 51%.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Botulinum Toxins market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Botulinum Toxins market. Detailed analysis of key players, along with key growth strategies adopted by Botulinum Toxins industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Ipsen

    • Medytox

    • Merz Pharmaceuticals

    • US World Meds

    • Allergan

    • LIBP

    By Type:

    • 50U

    • 100U

    • Other

    By End-User:

    • Medical

    • Cosmetic

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Botulinum Toxins Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Botulinum Toxins Market Size and Growth Rate of 50U from 2016 to 2027

      • 1.3.2 USA Botulinum Toxins Market Size and Growth Rate of 100U from 2016 to 2027

      • 1.3.3 USA Botulinum Toxins Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Botulinum Toxins Market Size and Growth Rate of Medical from 2016 to 2027

      • 1.4.2 USA Botulinum Toxins Market Size and Growth Rate of Cosmetic from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Botulinum Toxins Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Botulinum Toxins Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Botulinum Toxins Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Botulinum Toxins Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Botulinum Toxins Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Botulinum Toxins by Major Types

      • 3.4.1 Market Size and Growth Rate of 50U

      • 3.4.2 Market Size and Growth Rate of 100U

      • 3.4.3 Market Size and Growth Rate of Other

    4 Segmentation of Botulinum Toxins Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Botulinum Toxins by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Botulinum Toxins in Medical

      • 4.4.2 Market Size and Growth Rate of Botulinum Toxins in Cosmetic

    5 Market Analysis by Regions

    • 5.1 USA Botulinum Toxins Production Analysis by Regions

    • 5.2 USA Botulinum Toxins Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Botulinum Toxins Landscape Analysis

    • 6.1 West USA Botulinum Toxins Landscape Analysis by Major Types

    • 6.2 West USA Botulinum Toxins Landscape Analysis by Major End-Users

    7 South USA Botulinum Toxins Landscape Analysis

    • 7.1 South USA Botulinum Toxins Landscape Analysis by Major Types

    • 7.2 South USA Botulinum Toxins Landscape Analysis by Major End-Users

    8 Middle West USA Botulinum Toxins Landscape Analysis

    • 8.1 Middle West USA Botulinum Toxins Landscape Analysis by Major Types

    • 8.2 Middle West USA Botulinum Toxins Landscape Analysis by Major End-Users

    9 Northeast USA Botulinum Toxins Landscape Analysis

    • 9.1 Northeast USA Botulinum Toxins Landscape Analysis by Major Types

    • 9.2 Northeast USA Botulinum Toxins Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Ipsen

        • 10.1.1 Ipsen Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Medytox

        • 10.2.1 Medytox Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Merz Pharmaceuticals

        • 10.3.1 Merz Pharmaceuticals Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 US World Meds

        • 10.4.1 US World Meds Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Allergan

        • 10.5.1 Allergan Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 LIBP

        • 10.6.1 LIBP Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Botulinum Toxins Market Size and Growth Rate of 50U from 2016 to 2027

    • Figure USA Botulinum Toxins Market Size and Growth Rate of 100U from 2016 to 2027

    • Figure USA Botulinum Toxins Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Botulinum Toxins Market Size and Growth Rate of Medical from 2016 to 2027

    • Figure USA Botulinum Toxins Market Size and Growth Rate of Cosmetic from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Botulinum Toxins Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Botulinum Toxins Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Botulinum Toxins Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Botulinum Toxins Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Botulinum Toxins Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Botulinum Toxins

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Botulinum Toxins by Different Types from 2016 to 2027

    • Table Consumption Share of Botulinum Toxins by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of 50U

    • Figure Market Size and Growth Rate of 100U

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Botulinum Toxins by Different End-Users from 2016 to 2027

    • Table Consumption Share of Botulinum Toxins by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Medical

    • Figure Market Size and Growth Rate of Cosmetic

    • Table USA Botulinum Toxins Production by Regions

    • Table USA Botulinum Toxins Production Share by Regions

    • Figure USA Botulinum Toxins Production Share by Regions in 2016

    • Figure USA Botulinum Toxins Production Share by Regions in 2021

    • Figure USA Botulinum Toxins Production Share by Regions in 2027

    • Table USA Botulinum Toxins Consumption by Regions

    • Table USA Botulinum Toxins Consumption Share by Regions

    • Figure USA Botulinum Toxins Consumption Share by Regions in 2016

    • Figure USA Botulinum Toxins Consumption Share by Regions in 2021

    • Figure USA Botulinum Toxins Consumption Share by Regions in 2027

    • Table West USA Botulinum Toxins Consumption by Types from 2016 to 2027

    • Table West USA Botulinum Toxins Consumption Share by Types from 2016 to 2027

    • Figure West USA Botulinum Toxins Consumption Share by Types in 2016

    • Figure West USA Botulinum Toxins Consumption Share by Types in 2021

    • Figure West USA Botulinum Toxins Consumption Share by Types in 2027

    • Table West USA Botulinum Toxins Consumption by End-Users from 2016 to 2027

    • Table West USA Botulinum Toxins Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Botulinum Toxins Consumption Share by End-Users in 2016

    • Figure West USA Botulinum Toxins Consumption Share by End-Users in 2021

    • Figure West USA Botulinum Toxins Consumption Share by End-Users in 2027

    • Table South USA Botulinum Toxins Consumption by Types from 2016 to 2027

    • Table South USA Botulinum Toxins Consumption Share by Types from 2016 to 2027

    • Figure South USA Botulinum Toxins Consumption Share by Types in 2016

    • Figure South USA Botulinum Toxins Consumption Share by Types in 2021

    • Figure South USA Botulinum Toxins Consumption Share by Types in 2027

    • Table South USA Botulinum Toxins Consumption by End-Users from 2016 to 2027

    • Table South USA Botulinum Toxins Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Botulinum Toxins Consumption Share by End-Users in 2016

    • Figure South USA Botulinum Toxins Consumption Share by End-Users in 2021

    • Figure South USA Botulinum Toxins Consumption Share by End-Users in 2027

    • Table Middle West USA Botulinum Toxins Consumption by Types from 2016 to 2027

    • Table Middle West USA Botulinum Toxins Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Botulinum Toxins Consumption Share by Types in 2016

    • Figure Middle West USA Botulinum Toxins Consumption Share by Types in 2021

    • Figure Middle West USA Botulinum Toxins Consumption Share by Types in 2027

    • Table Middle West USA Botulinum Toxins Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Botulinum Toxins Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Botulinum Toxins Consumption Share by End-Users in 2016

    • Figure Middle West USA Botulinum Toxins Consumption Share by End-Users in 2021

    • Figure Middle West USA Botulinum Toxins Consumption Share by End-Users in 2027

    • Table Northeast USA Botulinum Toxins Consumption by Types from 2016 to 2027

    • Table Northeast USA Botulinum Toxins Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Botulinum Toxins Consumption Share by Types in 2016

    • Figure Northeast USA Botulinum Toxins Consumption Share by Types in 2021

    • Figure Northeast USA Botulinum Toxins Consumption Share by Types in 2027

    • Table Northeast USA Botulinum Toxins Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Botulinum Toxins Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Botulinum Toxins Consumption Share by End-Users in 2016

    • Figure Northeast USA Botulinum Toxins Consumption Share by End-Users in 2021

    • Figure Northeast USA Botulinum Toxins Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Ipsen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ipsen

    • Figure Sales and Growth Rate Analysis of Ipsen

    • Figure Revenue and Market Share Analysis of Ipsen

    • Table Product and Service Introduction of Ipsen

    • Table Company Profile and Development Status of Medytox

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medytox

    • Figure Sales and Growth Rate Analysis of Medytox

    • Figure Revenue and Market Share Analysis of Medytox

    • Table Product and Service Introduction of Medytox

    • Table Company Profile and Development Status of Merz Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merz Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Merz Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Merz Pharmaceuticals

    • Table Product and Service Introduction of Merz Pharmaceuticals

    • Table Company Profile and Development Status of US World Meds

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of US World Meds

    • Figure Sales and Growth Rate Analysis of US World Meds

    • Figure Revenue and Market Share Analysis of US World Meds

    • Table Product and Service Introduction of US World Meds

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of LIBP

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LIBP

    • Figure Sales and Growth Rate Analysis of LIBP

    • Figure Revenue and Market Share Analysis of LIBP

    • Table Product and Service Introduction of LIBP


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.